Hara, M. A., K. O. Mohamed, M. Ramadan, M. K. Abdelhameid, and E. S. Taher, "Pyroptosis and chemical classifcation of pyroptotic agents", Molecular Diversity, vol. 28, issue 5, pp. 1-18, 2024.
Aziz, M. W., K. O. Mohamed, D. B. Farag, A. K. Khalifa, and Z. Mahmoud, "Effective scaffolds as antihypertensive agents, a long story with happy endings; a review tracing the promising reported candidates", Journal of Molecular Structure, vol. 1319, issue 2, pp. 1-38, 2025. journal_molecular_structure_2025.pdf
Al-Warhi, T., K. O. Mohamed, M. Abualnaja, O. A. A. Ali, N. M. Alyamani, F. G. Elsaid, A. A. Shati, S. Albogami, E. Fayad, A. A. H. Almaaty, et al., "Design, Synthesis and Cytotoxicity Screening of New Thiazole Derivatives as Potential Anticancer Agents through VEGFR-2 Inhibition", Symmetry, vol. 14, issue 9, pp. 1-16, 2022.
Mohamed, K. O., A. Taher, A. Kasab, A. R. Mayhoub, M. M. Elsebaei, A. Elshewy, and I. G. Shahin, "New Phenylthiazoles: Design, Synthesis, and Biological Evaluation as Antibacterial, Antifungal,and Anti-COVID-19 Candidates", chemistry & biodiversity, vol. 20, issue 11, pp. 1-12, 2023.
Mohamed, K. O., N. S. M. Ibrahim, H. Kadry, and A. Zaher, "Review: synthesis and anticancer activity of pyrimido[4,5-b]quinolines in the last twenty years", chemical papers, vol. 78, issue 5, pp. 2695-2728, 2024.
Mohamed, K. O., N. S. M. Ibrahim, H. Kadry, and A. Zaher, "Synthesis of novel pyrimido[4,5‐b]quinoline derivatives as dual EGFR/HER2 inhibitors as anticancer agents", archive der pharmazie, vol. 357, issue 3, pp. 1-12, 2023.
Mohamed, K. O., N. S. M. Ibrahim, H. Kadry, and A. Zaher, "Synthesis of novel pyrimido[4,5-b]quinolines as potential anticancer agents and HER2 inhibitors", Chemical Biology & Drug Design, vol. 102, issue 5, pp. 996-1013, 2023.
Mohamed, K. O., L. W. Mohamed, H. S. Sayed, and Z. Mahmoud, "Recent modifications of anti-dementia agents focusing on tacrine and/or donepezil analogs", Medicinal Chemistry , vol. 19, issue 4, pp. 311-324, 2023.